Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): A phase 3, double-blind, randomised, multicentre, placebo-controlled trial
Beyond meeting metabolic demands, higher energy formulations enhance functional performance, satiety, and consumer satisfaction, thereby contributing to the advancement of evidence-based vegan sports nutrition and supporting the broader adoption of plant-based dietary strategies in athletic populations
Vitamin D3 shots may be prescribed to those with vitamin D deficiency, osteomalacia, osteoporosis, diabetes, and rickets
Without insurance or discount programs, tirzepatide costs $300 to $700 per month through various compounding pharmacies and direct programs
For individuals facing both migraines and depression, a multidisciplinary approach is essential
Sabemos, que la hiperglucemia crnica produce disfuncin de la clula beta caracterizada por disminucin de la biosntesis de insulina e incremento de los niveles de apoptosis (glucotoxicidad)